SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

20 May 2022 Evaluate
A minor change in the total revenue was seen in the March 2022 quarter. The total revenue for the quarter stood at Rs. 20193.00 millions against Rs. 20084.00 millions during year ago period.Profit after Tax for the quarter ended March 2022 saw a decline of -46.87% from Rs. 4647.00 millions to Rs. 2469.00  millions.The Operating Profit of the company witnessed a decrease to 5113.00 millions from 5773.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 20193.00 20084.00 0.54 79819.00 77800.00 2.60 79819.00 77800.00 2.60
Other Income 537.00 -165.00 -425.45 1787.00 893.00 100.11 1787.00 893.00 100.11
PBIDT 5113.00 5773.00 -11.43 20968.00 23980.00 -12.56 20968.00 23980.00 -12.56
Interest 420.00 205.00 104.88 1349.00 709.00 90.27 1349.00 709.00 90.27
PBDT 4693.00 5568.00 -15.71 16426.00 21396.00 -23.23 16426.00 21396.00 -23.23
Depreciation 1228.00 1150.00 6.78 4787.00 4511.00 6.12 4787.00 4511.00 6.12
PBT 3465.00 4418.00 -21.57 11639.00 16885.00 -31.07 11639.00 16885.00 -31.07
TAX 996.00 -229.00 -534.93 3060.00 2123.00 44.14 3060.00 2123.00 44.14
Deferred Tax 217.00 -784.00 -127.68 458.00 -910.00 -150.33 458.00 -910.00 -150.33
PAT 2469.00 4647.00 -46.87 8579.00 14762.00 -41.88 8579.00 14762.00 -41.88
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 25.32 28.74 -11.91 26.27 30.82 -14.77 26.27 30.82 -14.77

Zydus Lifesciences Share Price

1166.25 32.40 (2.86%)
15-Jul-2026 12:38 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1956.50
Dr. Reddys Labs. 1234.00
Cipla 1445.00
Zydus Lifesciences 1166.25
Lupin 2501.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: